AzurRx BioPharma Inc through its subsidiary is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Its products under development includes MS1819 and AZ1101.
$0.93
As of 04/09/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.